Contiguous Gene Syndromes and Hearing Loss: A Clinical Report of Xq21 Deletion and Comprehensive Literature Review

Genes (Basel). 2024 May 23;15(6):677. doi: 10.3390/genes15060677.

Abstract

Given the crucial role of the personalized management and treatment of hearing loss (HL), etiological investigations are performed early on, and genetic analysis significantly contributes to the determination of most syndromic and nonsyndromic HL cases. Knowing hundreds of syndromic associations with HL, little comprehensive data about HL in genomic disorders due to microdeletion or microduplications of contiguous genes is available. Together with the description of a new patient with a novel 3.7 Mb deletion of the Xq21 critical locus, we propose an unreported literature review about clinical findings in patients and their family members with Xq21 deletion syndrome. We finally propose a comprehensive review of HL in contiguous gene syndromes in order to confirm the role of cytogenomic microarray analysis to investigate the etiology of unexplained HL.

Keywords: IP3; Xq21 deletion; congenital hearing loss; contiguous gene syndrome; hearing loss; inner ear malformation; microarray; microdeletion; microduplication.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Chromosome Deletion*
  • Chromosomes, Human, X* / genetics
  • Female
  • Hearing Loss* / genetics
  • Humans
  • Male
  • Pedigree
  • Syndrome

Grants and funding

The research presented in the manuscript received funding from Institute for Maternal and Child Health-IRCCS “Burlo Garofolo”—Trieste (RC 17/23), nominated by the Italian Ministry of Health.